Literature DB >> 17352240

Expression of type 2 hexokinase and mitochondria-related genes in gastric carcinoma tissues and cell lines.

Minsuk Rho1, Jin Kim, Chang Do Jee, You Mie Lee, Hee Eun Lee, Min A Kim, Hye Seung Lee, Woo Ho Kim.   

Abstract

BACKGROUND: The constant overexpression of glycolysis and active mitochondrial function are critical for productive energy required for the immortal proliferation of cancer cells. The genes related to glycolysis and mitochondrial respiration might have some function during stomach carcinogenesis.
MATERIALS AND METHODS: The expression of hexokinase 2 (HK2), Bcl-2 and several mitochondria-related gene products were investigated by immunohistochemistry in 257 consecutive human gastric carcinomas, and the results were compared with the clinicopathological characteristics. In addition, transcriptional change of HK2 and Bcl-2 was investigated in the hypoxic state or with mitochondrial inhibitors.
RESULTS: In immunohistochemical analysis, HK2 was overexpressed in 43 out of 257 stomach cancer patients. Bcl-2 was not expressed in cases with HK2 positive cancer tissues except for one case, while the voltage-dependent anion channel, complex II and pyruvate dehydrogenase, located in mitochondria, were expressed in all cases. The patients with HK2 expression showed a worse prognosis compared to the HK2 negative cases, and patients who were negative in Bcl-2 and positive in HK2 represented the lowest survival rate. HK2 and Bcl-2 responded to hypoxia, but not to mitochondrial dysfunction while the cellular growth was severely repressed by mitochondrial inhibitors, indicating that transcriptional regulation of HK2 and Bcl-2 proceeds upstream of dysfunctional mitochondria.
CONCLUSION: HK2 was overexpressed in 16.7% of gastric carcinomas, and reciprocal expression pattern with Bcl-2. The HK2 positive cases showed a worse prognosis and aggressive character.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17352240

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  24 in total

1.  Reduced survival of patients with hepatocellular carcinoma expressing hexokinase II.

Authors:  Lei Gong; Zhuqingqing Cui; Pengcheng Chen; Hui Han; Jirun Peng; Xisheng Leng
Journal:  Med Oncol       Date:  2011-01-30       Impact factor: 3.064

2.  Association of overexpression of hexokinase II with chemoresistance in epithelial ovarian cancer.

Authors:  Dong Hoon Suh; Min A Kim; Haeryoung Kim; Mi-Kyung Kim; Hee Seung Kim; Hyun Hoon Chung; Yong-Beom Kim; Yong Sang Song
Journal:  Clin Exp Med       Date:  2013-08-15       Impact factor: 3.984

Review 3.  Glucose metabolism in gastric cancer: The cutting-edge.

Authors:  Lian-Wen Yuan; Hiroharu Yamashita; Yasuyuki Seto
Journal:  World J Gastroenterol       Date:  2016-02-14       Impact factor: 5.742

4.  Expressions of hypoxia-inducible factor-1α and hexokinase-II in gastric adenocarcinoma: the impact on prognosis and correlation to clinicopathologic features.

Authors:  Miao-Zhen Qiu; Bing Han; Hui-Yan Luo; Zhi-Wei Zhou; Zhi-Qiang Wang; Feng-Hua Wang; Yu-Hong Li; Rui-Hua Xu
Journal:  Tumour Biol       Date:  2010-09-16

Review 5.  Translational research in brain metastasis is identifying molecular pathways that may lead to the development of new therapeutic strategies.

Authors:  Brunilde Gril; Lynda Evans; Diane Palmieri; Patricia S Steeg
Journal:  Eur J Cancer       Date:  2010-03-19       Impact factor: 9.162

Review 6.  Cancer's craving for sugar: an opportunity for clinical exploitation.

Authors:  S Yeluri; B Madhok; K R Prasad; P Quirke; D G Jayne
Journal:  J Cancer Res Clin Oncol       Date:  2009-05-05       Impact factor: 4.553

7.  Kaempferol inhibits cell proliferation and glycolysis in esophagus squamous cell carcinoma via targeting EGFR signaling pathway.

Authors:  Shihua Yao; Xiaowei Wang; Chunguang Li; Tiejun Zhao; Hai Jin; Wentao Fang
Journal:  Tumour Biol       Date:  2016-02-01

8.  Analyses of resected human brain metastases of breast cancer reveal the association between up-regulation of hexokinase 2 and poor prognosis.

Authors:  Diane Palmieri; Daniel Fitzgerald; S Martin Shreeve; Emily Hua; Julie L Bronder; Robert J Weil; Sean Davis; Andreas M Stark; Maria J Merino; Raffael Kurek; H Maximilian Mehdorn; Gary Davis; Seth M Steinberg; Paul S Meltzer; Kenneth Aldape; Patricia S Steeg
Journal:  Mol Cancer Res       Date:  2009-09-01       Impact factor: 5.852

9.  Gene expression meta-analysis identifies VDAC1 as a predictor of poor outcome in early stage non-small cell lung cancer.

Authors:  Claire Grills; Puthen V Jithesh; Jaine Blayney; Shu-Dong Zhang; Dean A Fennell
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240

10.  Anticancer targets in the glycolytic metabolism of tumors: a comprehensive review.

Authors:  Paolo E Porporato; Suveera Dhup; Rajesh K Dadhich; Tamara Copetti; Pierre Sonveaux
Journal:  Front Pharmacol       Date:  2011-08-25       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.